Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

“There are things that we can do at all stages of our lives deliberately,” says Prof Schott. “It’s never too early to start ...

The risk of developing dementia may be much higher than previously thought, a study published Monday in the journal Nature Medicine has found.

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...

They watched as dementia stole their parents’ memories, strength and finally their independence. Three daughters share the ...

ROTHERHAM'S first interactive dementia conference brought together people with lived experience as well as health and civic ...

Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...

The science-fiction sounding prospect of such a jab capable of combating the 'internal enemies' of ageing could easily be ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...